IceCure Medical (NASDAQ:ICCM) & OrthoPediatrics (NASDAQ:KIDS) Head-To-Head Analysis

IceCure Medical (NASDAQ:ICCM) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations.

Insider and Institutional Ownership

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares IceCure Medical and OrthoPediatrics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-410.22%	-111.27%	-81.41%
OrthoPediatrics	-14.35%	-5.44%	-4.67%

Valuation & Earnings

This table compares IceCure Medical and OrthoPediatrics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.34 million	7.52	-$14.65 million	($0.33)	-1.67
OrthoPediatrics	$175.07 million	3.51	-$20.97 million	($0.96)	-26.90

IceCure Medical has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

IceCure Medical has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for IceCure Medical and OrthoPediatrics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0	0	2	0	3.00
OrthoPediatrics	0	1	2	0	2.67

IceCure Medical presently has a consensus price target of $2.70, indicating a potential upside of 390.91%. OrthoPediatrics has a consensus price target of $40.00, indicating a potential upside of 54.92%. Given IceCure Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe IceCure Medical is more favorable than OrthoPediatrics.

Summary

OrthoPediatrics beats IceCure Medical on 7 of the 13 factors compared between the two stocks.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.